Patents by Inventor Anna Maria SLAGER

Anna Maria SLAGER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Optimized Synthetic Consensus Immunogenic Compositions Targeting the Follicle Stimulating Hormone Receptor (FSHR)
    Publication number: 20240115680
    Abstract: Provided herein is an immunogenic composition comprising a synthetic consensus antigen to Follicle Stimulating Hormone Receptor (FSHR) protein which is abundant in many ovarian cancer sub-types. Also disclosed herein is a method of treating a tumor associated pathology in a subject in need thereof, by administering the immunogenic composition to the subject.
    Type: Application
    Filed: December 15, 2023
    Publication date: April 11, 2024
    Inventors: David Weiner, Alfredo Perales Puchalt, Jian Yan, Anna Maria Slager
  • Nucleic acid encoding optimized immunogenic peptide that targets follicle stimulating hormone receptor
    Patent number: 11865166
    Abstract: Provided herein is an immunogenic composition comprising a synthetic consensus antigen to Follicle Stimulating Hormone Receptor (FSHR) protein which is abundant in many ovarian cancer sub-types. Also disclosed herein is a method of treating a tumor associated pathology in a subject in need thereof, by administering the immunogenic composition to the subject.
    Type: Grant
    Filed: August 29, 2017
    Date of Patent: January 9, 2024
    Assignees: The Trustees of the University of Pennsylvania, Inovio Pharmaceuticals, Inc., The Wistar Institute of Anatomy and Biology
    Inventors: David Weiner, Alfredo Perales Puchalt, Jian Yan, Anna Maria Slager
  • Optimized Synthetic Consensus Immunogenic Compositions Targeting the Follicle Stimulating Hormone Receptor (FSHR)
    Publication number: 20190192644
    Abstract: Provided herein is an immunogenic composition comprising a synthetic consensus antigen to Follicle Stimulating Hormone Receptor (FSHR) protein which is abundant in many ovarian cancer sub-types. Also disclosed herein is a method of treating a tumor associated pathology in a subject in need thereof, by administering the immunogenic composition to the subject.
    Type: Application
    Filed: August 29, 2017
    Publication date: June 27, 2019
    Inventors: David WEINER, Alfredo PERALES PUCHALT, Jian YAN, Anna Maria SLAGER